Have a personal or library account? Click to login
Importance of Classic Cardiovascular Risk Factors and Inflammatory Markers in St-Elevation Acute Myocardial Infarction Cover

Importance of Classic Cardiovascular Risk Factors and Inflammatory Markers in St-Elevation Acute Myocardial Infarction

Open Access
|Mar 2025

References

  1. Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Socienty of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal of Myocardial Infarction (2018). J AmColl Cardiol 2018; pii; S0735-1097(18)36941-9.
  2. Carmen Ginghină. Mic tratat de cardiologie 2017, Editura Academiei Romane: 291-379.
  3. Cunha PG, Boutouyrie P, Nilsson PM, et al. Early Vascular Ageing (EVA): Definitions and Clinical Applicability. Curr Hypertens Rev.2017;13(1):8-15.
  4. Ibanez B, James S, Agewall S, Antunes MJ, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-177.
  5. Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014;383:999 1008.
  6. Damen JA, Hooft L, Schuit E, et al. Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 2016;353:i2416.
  7. Ginghină C. Mic tratat de cardiologie. București: Editura Academiei Române;2017:175-187.
  8. Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39,3021-3104.
  9. Mach F, Baigent C, Catapano A, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modifications to reduce cardiovascular risk. Eur Heart J. 2020;41,111-188.
  10. Gaita D, Mosteoru S. Metabolically healthy versus unhealthy obesity and risk for diabetes vascular Endocrinology&Metabolism. 2017;6(1):23-26.
  11. Cosentino F, Grant PJ C, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular disease developed in collaboration with EASD. Eur Heart J. 2020;41,255-323.
  12. Mitchell S, Malanda B, ...Gaita D, et al. A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes. Global Heart. 2019;14: 215-40.
  13. Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC Focused update on dual antiplatelet therapy in coronary artery disease developed in colaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J.2018;39(3):213-260.
  14. Littnerova S, Kala P, Jarkovsky J. GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarctions. PLoS One. 2015 Apr 20;10(4):e0123215.
DOI: https://doi.org/10.2478/inmed-2024-0310 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 87 - 94
Published on: Mar 18, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Alexandra Manuela Buzle, Priscilla Pașc, Mădălina Ioana Moisi, Mircea Ioachim Popescu, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.